These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24103189)

  • 1. Cardiovascular safety trials: be careful what you wish for.
    Bloomgarden Z; Grunberger G
    J Diabetes; 2014 Jan; 6(1):1-3. PubMed ID: 24103189
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs and clinical trials in diabetes and hypertension.
    Nilsson P
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Positioning of PROactive and its clinical application in Japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: discussion].
    Kawamori R; Kadowaki T; Daida H; Takeda N; Dormandy J
    Nihon Rinsho; 2006 Mar; 64(3):581-7. PubMed ID: 16732624
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-diabetic therapy and cardiovascular disease].
    Mannucci E
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidiabetic agents and vascular events.
    Keen H
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacology of oral antidiabetic agents (second of two parts).
    Shen SW; Bressler R
    N Engl J Med; 1977 Apr; 296(14):787-93. PubMed ID: 320484
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing new drugs for diabetes and cardiometabolic disorders: a changing paradigm.
    Krentz AJ; Morrow L; Hompesch M
    Drugs; 2012 Sep; 72(13):1709-11. PubMed ID: 22931519
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
    Calle-Pascual A; Garcia-Honduvilla J; Martin-Alvarez PJ; Calle JR; Maranes JP
    Diabetes Metab; 1996 Jun; 22(3):201-2. PubMed ID: 8697309
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug safety. Planned study of Avandia in doubt after FDA review.
    Kean S
    Science; 2010 Jul; 329(5990):375. PubMed ID: 20651123
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiologists and the management of blood sugar: a Chinese perspective.
    Hu DY; Guo YF
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711
    [No Abstract]   [Full Text] [Related]  

  • 13. Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes?
    Giorda CB
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e47-8. PubMed ID: 21035888
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk reduction with pioglitazone.
    Cardiovasc J S Afr; 2002; 13(4):218. PubMed ID: 12402932
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA; Tuttle KR
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
    Kengne AP; Patel A
    PLoS Med; 2006 Oct; 3(10):e424. PubMed ID: 17048981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rehabilitation of oral hypoglycemic agents].
    Biron P
    Union Med Can; 1975 Sep; 104(9):1421-4. PubMed ID: 1179546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of diabetes mellitus with a mixture of oral hypoglycemic agents].
    Quibrera R; Nava M; Grimaldo JI
    Gac Med Mex; 1979 Mar; 115(3):121-6. PubMed ID: 378748
    [No Abstract]   [Full Text] [Related]  

  • 20. Top 10 facts you should know about diabetes.
    Call RJ; Wofford MR; Riche DM
    J Miss State Med Assoc; 2012 Aug; 53(8):275-7. PubMed ID: 23094391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.